In ancient days, when a watchman on Israel’s walls detected an approaching enemy, the first thing he did was grab his shofar.

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Eli Lilly’s acquisition of gene therapy specialist Akouos seems to have paid off, after the lead candidate in the deal restored hearing in a child with congenital deafness. The AK-OTOF therapy ...

Making the choice between buying a new Apple MacBook Air vs MacBook Pro buying decision is trickier than ever because while both are great laptops, they excel at different things and come in a ...